Models, Econometric Concept

subject area of

• A comparison of alternative models of prescription drug utilization  Journal Articles
• A discrete choice experiment investigating preferences for funding drugs used to treat orphan diseases: an exploratory study  Journal Articles
• A managerial approach to costing fixed assets in health care Organizations: The role of depreciation and interest  Journal Articles
• A practical methodology for disaggregating the drivers of drug costs using administrative data  Journal Articles
• A re-examination of the meaning and importance of supplier-induced demand  Journal Articles
• Access to physician services: does supplemental insurance matter? Evidence from France  Journal Articles
• An economic evaluation of surgery versus collagen injection for the treatment of female stress urinary incontinence.  Journal Articles
• An opportunity cost approach to sample size calculation in cost‐effectiveness analysis  Journal Articles
• Assessing cost‐effectiveness in asthma care: building an economic model to study the impact of alternative intervention strategies  Conferences
• Attributing a monetary value to patients' time: A contingent valuation approach  Journal Articles
• Canada's Population Health Model (POHEM)  Journal Articles
• Cost comparison of four revascularisation procedures for the treatment of multivessel coronary artery disease  Journal Articles
• Cost effectiveness/utility analyses  Journal Articles
• Cost per remission and cost per response with infliximab, adalimumab, and golimumab for the treatment of moderately-to-severely active ulcerative colitis  Journal Articles
• Cost prediction models for the comparison of two groups  Journal Articles
• Cost-Effectiveness and Cost-Utility of Long-Term Management Strategies for Heartburn  Journal Articles
• Cost-effectiveness of Apligraf in the treatment of venous leg ulcers.  Journal Articles
• Cost-effectiveness of becaplermin for nonhealing neuropathic diabetic foot ulcers.  Journal Articles
• Cost-effectiveness of denosumab in the treatment of postmenopausal osteoporosis in Canada  Journal Articles
• Cost‐effectiveness analysis of a multinational RCT with a binary measure of effectiveness and an interacting covariate  Journal Articles
• Cost‐effectiveness of clopidogrel in acute coronary syndromes in Sweden: a long‐term model based on the cure trial  Journal Articles
• Determining the optimal model for role-substitution in NHS dental services in the United Kingdom  Journal Articles
• Discounting in the Economic Evaluation of Health Care Interventions  Journal Articles
• Does free complementary health insurance help the poor to access health care? Evidence from France  Journal Articles
• Double discounting of QALYs  Journal Articles
• Economic analysis of epoetin alfa in critically ill trauma patients  Journal Articles
• Economic evaluation of nivolumab for the treatment of second-line advanced squamous NSCLC in Canada: a comparison of modeling approaches to estimate and extrapolate survival outcomes  Journal Articles
• Economics, health and health economics: HYEs versus QALYs  Journal Articles
• Editorial: Response to Pauly on a re-examination of the meaning and importance of supplier-induced demand  Journal Articles
• Equity considerations in utility-based measures of health outcomes in economic appraisals: An adjustment algorithm  Journal Articles
• Estimating the price elasticity of expenditure for prescription drugs in the presence of non‐linear price schedules: an illustration from Quebec, Canada  Conferences
• Expected value of information and decision making in HTA  Journal Articles
• Exploring the effects of population change on the costs of physician services  Journal Articles
• Family income, parenting styles and child behavioural–emotional outcomes  Journal Articles
• Health Human Resource Planning in Home Care: How to Approach It - That Is the Question  Journal Articles
• Health care policy evaluation using longitudinal insurance claims data: An application of the Panel Tobit estimator  Conferences
• Health expenditure growth: reassessing the threat of ageing  Journal Articles
• Healthcare resource utilization in patients receiving idarucizumab for reversal of dabigatran anticoagulation due to major bleeding, urgent surgery, or procedural interventions: interim results from the RE-VERSE AD™ study  Journal Articles
• Implications of basing health-care resource allocations on cost-utility analysis in the presence of externalities  Journal Articles
• In Search of Power and Significance: Issues in the Design and Analysis of Stochastic Cost-Effectiveness Studies in Health Care  Journal Articles
• Incremental net benefit in the analysis of economic data from clinical trials, with application to the CADET-Hp Trial  Journal Articles
• International Efforts in Health Care Reform: Systemic Treatment Funding Model Reform in Ontario  Journal Articles
• Is there a kink in consumers' threshold value for cost‐effectiveness in health care?  Journal Articles
• Life-expectancy gains from pharmaceutical drugs: a critical appraisal of the literature  Journal Articles
• Methods for Patient-Level Costing in the VA System: Are they Applicable to Canada?  Journal Articles
• Methods for assessing relative importance in preference based outcome measures  Journal Articles
• Methods for patient-level costing in the VA system: Are they applicable to Canada?  Journal Articles
• Most guideline organizations lack explicit guidance in how to incorporate cost considerations  Journal Articles
• Opportunity costs and uncertainty in the economic evaluation of health care interventions  Journal Articles
• Optimizing a portfolio of health care programs in the presence of uncertainty and constrained resources  Journal Articles
• Past world economic production constrains current energy demands: Persistent scaling with implications for economic growth and climate change mitigation  Journal Articles
• Portfolio theory and the alternative decision rule of cost-effectiveness analysis: theoretical and practical considerations  Journal Articles
• Preference based outcome measures for economic evaluation of drug interventions: quality adjusted life years (QALYs) versus healthy years equivalents (HYEs).  Journal Articles
• Productivity costs, time costs and health-related quality of life: a response to the Erasmus Group  Journal Articles
• Publicly funded medical savings accounts: expenditure and distributional impacts in Ontario, Canada  Journal Articles
• Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts’ consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the US branch of the International Osteoporosis Foundation  Journal Articles
• Relative fees and the utilization of physicians' services in Canada  Journal Articles
• Sample size and power issues in estimating incremental cost-effectiveness ratios from clinical trials data  Journal Articles
• Selecting effective incentive structures in health care: A decision framework to support health care purchasers in finding the right incentives to drive performance  Journal Articles
• Socio-economic status, health and lifestyle  Journal Articles
• Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost‐effectiveness analysis  Journal Articles
• The Impact of Reference Pricing of Nonsteroidal Anti‐Inflammatory Agents on the Use and Costs of Analgesic Drugs  Journal Articles
• The Use of Economic Evaluation in Hand Surgery  Journal Articles
• The additive utility assumption of the QALY model revisited  Journal Articles
• The cost of drug development: A systematic review  Journal Articles
• The costs and effects of addressing the needs of vulnerable populations: results of 10 years of research.  Journal Articles
• The distribution problem in economic evaluation: income and the valuation of costs and consequences of health care programmes  Journal Articles
• The effects of drug subsidies on out-of-pocket prescription drug expenditures by seniors: regional evidence from Canada  Journal Articles
• The health economics of Helicobacter pylori infection  Journal Articles
• The relationship between physician fees and the utilization of medical services in Ontario.  Journal Articles
• The transition from good to poor health: an econometric study of the older population  Journal Articles
• Time preference, the discounted utility model and health  Journal Articles
• Transferability of economic evaluations: approaches and factors to consider when using results from one geographic area for another  Journal Articles
• Understanding Costs and Cost-Effectiveness in Critical Care  Journal Articles
• Using simulation‐based inference with panel data in health economics  Journal Articles